About Active Genomes Expressed Diagnostics
Active Genomes Expressed Diagnostics is a private company based in Washington, District of Columbia, incorporated in 2021 in District Of Columbia. It has reported $250,000 raised in one offering on Form D since February 2023. Its chief executive is Rachel Zayas.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 29, 2022 | Feb 15, 2023 | $250,000of $1.7M target | 2 | $125K | Debt, OptionsRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Active Genomes Expressed Diagnostics's Form D filed Feb 15, 2023.
RZ
Rachel Zayas
CEO and director